ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176327; 2) Community: the network communities that were significantly associated with the response to NSC 176327; 3) Molecule: the relationships between components within communities and NSC 176327; 4) MDR: the compounds that were significantly associated with the NSC 176327.

NSC Compound Enrichment Correlation
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.011265111688021 0.06825798
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.011265111688021 -0.079180262
NSC 758670 TANNIC ACID 0.011265111688021 0.27684452
NSC 292147 12-Hydroxyindolo[2,1-b]quinazoline-6(12H)-one 0.011544784012433 -0.3562243
NSC 629924 Null 0.011544784012433 0.20267142
NSC 668494 Null 0.011544784012433 0.39330186
NSC 677411 HWA 486 0.011544784012433 -0.035242381
NSC 731806 Null 0.011544784012433 0.30318087
NSC 736394 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.011544784012433 0.51111794
NSC 753938 2,7-bis(3-(dimethylamino)propyl)-4,10-bis(3-(dimethylamino)propylamino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone 0.011544784012433 0.15138553
Total:41  Current:10    [First] [Prev] [Next] [Last]